Winshine Science Flags Wider 2025 Loss on U.S. Tariffs and Rising China Costs

The latest update is out from Winshine Science Co., Ltd. ( (HK:0209) ).

Winshine Science Company Limited has warned that its loss attributable to shareholders for the year ended 31 December 2025 is expected to widen to not more than HK$95 million, compared with a loss of about HK$73 million a year earlier. The deterioration is mainly driven by weaker revenue and profits following higher U.S. tariffs on Chinese imports, which reduced order volumes and gross profit from U.S. sales, alongside higher labour and social insurance costs in China.

The board stressed that the figures are based on unaudited management accounts and that final 2025 results will be published by the end of March 2026, urging shareholders and potential investors to exercise caution when dealing in the company’s shares. The anticipated larger loss underlines the company’s vulnerability to trade policy shifts and rising mainland cost pressures, factors that may weigh on its competitiveness and investor sentiment in the near term.

The most recent analyst rating on (HK:0209) stock is a Hold with a HK$0.21 price target. To see the full list of analyst forecasts on Winshine Science Co., Ltd. stock, see the HK:0209 Stock Forecast page.

More about Winshine Science Co., Ltd.

Winshine Science Company Limited is a Bermuda-incorporated company listed in Hong Kong, operating through a group structure and deriving a significant portion of its revenue from sales to U.S. customers. The group’s cost base is heavily exposed to mainland China, where rising minimum wages and social insurance expenses are affecting its operating margins.

Average Trading Volume: 7,308,361

Technical Sentiment Signal: Hold

Current Market Cap: HK$742.8M

For an in-depth examination of 0209 stock, go to TipRanks’ Overview page.